Table 2 Drug use
From: Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Variables | Admission (N = 440) | 3 Months (N = 307) | 6 Months (N = 260) | 12 Months (N = 153) |
|---|---|---|---|---|
Fentanyl/Heroin, N (%) | 287 (65%) | 43 (14%) | 15 (6%) | 7 (5%) |
Codeine/Tylenol 3/4, N (%) | 108 (25%) | 12 (4%) | 6 (2%) | 0 (0%) |
Hydromorphone, N (%) | 118 (27%) | 5 (2%) | 2 (1%) | 2 (1%) |
Oxycodone, N (%) | 176 (40%) | 9 (3%) | 7 (3%) | 0 (0%) |
Methadone, N (%) | 88 (20%) | 25 (8%) | 18 (7%) | 18 (12%) |
Morphine, N (%) | 102 (23%) | 12 (4%) | 1 (0%) | 2 (1%) |
Other Opioids Used, N (%) | 53 (12%) | 0 (0%) | 3 (1%) | 0 (0%) |
Cocaine/Crack Cocaine, N (%) | 127 (29%) | 27 (9%) | 20 (8%) | 9 (6%) |
Amphetamines, N (%) | 21 (5%) | 7 (2%) | 5 (2%) | 3 (2%) |
Methamphetamines, N (%) | 107 (24%) | 28 (9%) | 12 (5%) | 6 (4%) |
Benzodiazepines/Tranquilizers, N (%) | 121 (28%) | 36 (12%) | 25 (10%) | 18 (12%) |
Other Drug Use, N (%) | 31 (7%) | 19 (6%) | 18 (7%) | 15 (10%) |
Missing, N (%) | 3 (1%) | 3 (1%) | 3 (1%) | 3 (2%) |